Pharmaceutical Litigation

Every year, thousands of people die from, or are seriously injured, as a result of taking prescription drugs and over the counter remedies they believe are safe. Many of these drugs have not been sufficiently tested or have inadequate warnings on their labels. Patients trust these defective drugs will not harm them because they have been approved by the U.S. Food and Drug Administration, or been prescribed by doctors they know and trust. Unfortunately in the rush to get new drugs on the market, drug companies frequently put pressure on the FDA to approve drugs quickly. As a result some of these drugs/medications are not sufficiently tested so as to discover their potential adverse effects. Drug manufacturers have an obligation and responsibility to fully test the drugs they put in the marketplace as well as to fully warn both the physicians to whom they aggressively promote the use of these drugs, as well as to the patients to whom they market them thru direct consumer advertising of all potential side effects and harm related to their use so that you, the consumer, can make an informed decision about taking them.

Williams Cuker Berezofsky has successfully represented individuals and prosecuted class actions on behalf of people harmed by the use of pharmaceutical products that have not been adequately tested and which are not labeled with all important risk information. The following are some of the drug product litigation we are involved in:

• Hormone Replacement
• Orthro-Evra®
• Vioxx
• Diet Drugs
• Heparin
• Gadolinium
• Chantix
• Rezulin
• Vytorin/Zetia

To consult with a member of the firm's Pharmaceutical Litigation practice group, please submit a confidential case inquiry form.